Skip to content

111, Inc.

YI · XNAS

CIK 1738906fmd_1KX4DADR8YBWNKXGS0PSXWK52NRetail Trade · Retail-Drug Stores and Proprietary StoresTemplate: Standard

Coverage: Jan 01, 2016 to Dec 31, 2025, 10 periods

Income Statement · Annual · Millions · CNY
Line itemFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Total revenues8749591,7863,9528,20312,42613,51714,94814,40112,556
Cost of revenue–56743,7877,83711,80512,67714,09913,57211,833
Gross profit7480104165366621840849829723
Provision for credit losses–––0000000
Selling, general and administrative314244359464528720664673385328
Operating income(364)(254)(400)(494)(473)(642)(371)(350)2(2)
Interest expense10–49513202836
Interest and investment income24456108974
Other non-operating income (expense)(3)412131588(1)11
Income before taxes(363)(249)(382)(502)(467)(621)(376)(353)(21)(23)
Income tax expense––00000000
Net income from continuing operations––(382)(502)(467)(621)(376)(353)(21)(23)
Net income(363)(249)(382)(502)(467)(621)(376)(353)(21)(23)
Net income to common shareholders(418)(249)(380)(500)(457)(670)(417)(393)(65)(66)